A human iPSC-CM model for type 1 catecholaminergic polymorphic ventricular tachycardia (CPVT1)
Year: 2019
Type: article
Abstract: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a devastating, heritable cardiac arrhythmia and often a cause of sudden cardiac death.Greater than 50% of cases of CPVT are due to genetic variants in the cardiac ryanodine receptor (RyR2).CPVT-associated RyR2 variants often result in gain-of-function phenotypes, producing a dominantly inherited and difficult to treat disease.Human induced pluripotent stem cells (hiPSCs) have been used to generate patient-specific hiPSCderived cardiomyocytes (hiPSC-CM) to study CPVT phenotypes and pharmacological approaches, however generating hiPSCs from patients is low through-put and lacks true isogenic controls.Therefore, this thesis aimed to use CRIPSR/Cas9 genome-editing technology to generate hiPSC cells lines harbouring a CPVT-associated variant.Genome-edited hiPSCs were differentiated into 2D tissue-like monolayers of hiPSC-CMs, and voltage and calcium dynamics were measured.This thesis indicates that CRISPR/Cas9 is a useful technology for studying CPVT in an in vitro human model, and that the R417L mutant disrupts hiPSC-CM calcium handling.
Source: Summit (Simon Fraser University)
Author: Drake A. Comber
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3004375671
